TGA Approval

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield (302463)

ARTG ID

302463

ARTG Name

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield

Sponsor

Sanofi-Aventis Australia Pty Ltd

ARTG Date

May 28, 2019

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Sponsor Item Name

SANOFI-AVENTIS AUSTRALIA PTY LTD

https://medical-cdn.nocode.com/drug_tga/30fd823fe34d32cf01f3171c22464510.pdf

https://medical-cdn.nocode.com/drug_tga/ffdf4d845b4cf3bb2db817e2109e341f.pdf

Ingredient Name

dupilumab

Empowering clinical research with data-driven insights and AI-powered tools.

DUPIXENT dupilumab 200 mg (175 mg/mL) solution for injection pre-filled syringe with needle shield (302463) - TGA 批准文号 | MedPath